Cancer fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma (ChRCC) and those that are present are indifferent to the ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...

Peter Redweik’s brutal infection was quelled by a medication so powerful that doctors use it sparingly. Yet he continued to ...

Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...

Trained immunity in alveolar macrophages can lead to damaging lung inflammation, confirming the importance of context in this phenomenon.

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

Scientists tracked how human immune cells attack pig kidneys after transplant—and found a way to fight back using precision ...

According to Regeneron, the drug is a bispecific antibody that binds to B-cell maturation antigen (BCMA) on cancerous plasma cells and CD3 on T cells, directing the immune system to attack and destroy ...